{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:21:52Z","timestamp":1772223712520,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijwd.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T14:19:26Z","timestamp":1573136366000},"page":"308-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD),,"],"prefix":"10.1097","volume":"5","author":[{"given":"Jodie","family":"Raffi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raagini","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Botto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny E.","family":"Murase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"5","key":"10.1016\/j.ijwd.2019.10.001_b0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0536.2006.00927.x","article-title":"The aetiology of eyelid dermatitis: a 10-year retrospective analysis","volume":"55","author":"Amin","year":"2006","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.ijwd.2019.10.001_b0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/cod.13040","article-title":"Is a specific eyelid patch test series useful? results of a French prospective study","volume":"79","author":"Assier","year":"2018","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ijwd.2019.10.001_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01634989-200306000-00004","article-title":"Eyelid dermatitis: An evaluation of 447 patients","volume":"14","author":"Ayala","year":"2003","journal-title":"Am J Contact Dermat"},{"issue":"5","key":"10.1016\/j.ijwd.2019.10.001_b0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/bjd.17538","article-title":"Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis","volume":"180","author":"Bakker","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.10.001_b0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajoc.2017.06.017","article-title":"Cicatricial ectropion in a patient treated with dupilumab","volume":"7","author":"Barnes","year":"2017","journal-title":"Am J Ophthalmic Case Rep"},{"issue":"10086","key":"10.1016\/j.ijwd.2019.10.001_b0035","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): A 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijwd.2019.10.001_b0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/DER.0000000000000208","article-title":"A pragmatic approach to patch testing atopic dermatitis patients. Clinical recommendations based on expert consensus opinion","volume":"27","author":"Chen","year":"2016","journal-title":"Dermatitis"},{"key":"10.1016\/j.ijwd.2019.10.001_b0045","first-page":"291","article-title":"Eyelid dermatitis: an evaluation of 232 patch test patients over 5 years","volume":"42","author":"Cooper","year":"2000","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.ijwd.2019.10.001_b0050","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/DER.0000000000000209","article-title":"Contact sensitization to emulsifying agents: An underrated issue?","volume":"27","author":"Corazza","year":"2016","journal-title":"Dermatitis"},{"key":"10.1016\/j.ijwd.2019.10.001_b0055","first-page":"25","article-title":"Case report: first reported case of facial rash after dupilumab therapy","author":"Dalia","year":"2018","journal-title":"Pract Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.10.001_b0060","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2019.10.001_b0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/DER.0000000000000417","article-title":"North American contact dermatitis group patch test results 2015\u20132016","volume":"29","author":"DeKoven","year":"2018","journal-title":"Dermatitis"},{"key":"10.1016\/j.ijwd.2019.10.001_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cod.13137","article-title":"Contact sensitization to hydroperoxides of limonene and linalool: results of consecutive patch testing and clinical relevance","volume":"80","author":"Dittmar","year":"2019","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.ijwd.2019.10.001_b0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.alit.2018.12.012","article-title":"Development of conjunctivitis with a conjunctival proliferative lesion in a patient treated with dupilumab for atopic dermatitis","volume":"68","author":"Fukuda","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.ijwd.2019.10.001_b0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.0105-1873.2004.00311.x","article-title":"Eyelid dermatitis: a report of 215 patients","volume":"50","author":"Guin","year":"2004","journal-title":"Contact Dermatitis"},{"issue":"4","key":"10.1016\/j.ijwd.2019.10.001_b0090","doi-asserted-by":"crossref","first-page":"1070Y1071","DOI":"10.1016\/j.jaci.2014.07.066","article-title":"Is there a risk using hypoallergenic cosmetic pediatric products in the United States?","volume":"135","author":"Hamann","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.10.001_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.ijwd.2019.10.001_b0100","doi-asserted-by":"crossref","first-page":"1916Y1924","DOI":"10.1016\/j.intimp.2011.07.025","article-title":"The elicitation step of nickel allergy is promoted in mice by microbe-related substances, including some from oral bacteria","volume":"11","author":"Huang","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.10.001_b0105","doi-asserted-by":"crossref","first-page":"129Y134","DOI":"10.1038\/sj.jid.5700582","article-title":"Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients","volume":"127","author":"Jakasa","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.10.001_b0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/DER.0000000000000240","article-title":"Alkyl glucosides in contact dermatitis","volume":"28","author":"Loranger","year":"2017","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.ijwd.2019.10.001_b0115","doi-asserted-by":"crossref","first-page":"801Y806","DOI":"10.1111\/j.1398-9995.2008.01890.x","article-title":"Giordano-Labadie F. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children","volume":"64","author":"Mailhol","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.ijwd.2019.10.001_b0120","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0536.1997.tb00398.x","article-title":"Discrepancy in patch test results with wool wax alcohols and AmercholR L-101","volume":"36","author":"Matthieu","year":"1997","journal-title":"Contact dermatitis"},{"issue":"3","key":"10.1016\/j.ijwd.2019.10.001_b0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40123-019-0191-9","article-title":"Ocular surface diseases induced by dupilumab in severe atopic dermatitis","volume":"8","author":"Maudinet","year":"2019","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ijwd.2019.10.001_b0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.det.2018.07.005","article-title":"Contact dermatitis: emerging trends","volume":"37","author":"Milam","year":"2019","journal-title":"Dermatol Clin"},{"issue":"11","key":"10.1016\/j.ijwd.2019.10.001_b0135","doi-asserted-by":"crossref","first-page":"1402Y1407","DOI":"10.1001\/archderm.1994.01690110068008","article-title":"Hanifin JM. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis","volume":"130","author":"Nassif","year":"1994","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.10.001_b0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/DER.0000000000000318","article-title":"Contact allergy to hydroperoxides of linalool and D-limonene in a U.S. Population","volume":"28","author":"Nath","year":"2017","journal-title":"Dermatitis"},{"key":"10.1016\/j.ijwd.2019.10.001_b0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000245712","article-title":"Contact allergy in patients with periorbital eczema: an analysis of allergens","volume":"195","author":"Ockenfels","year":"1997","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.ijwd.2019.10.001_b0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/DER.0000000000000251","article-title":"Patch test reactions to corticosteroids: Retrospective analysis from the North American Contact Dermatitis Group 2007\u20132014","volume":"28","author":"Pratt","year":"2018","journal-title":"Dermatitis"},{"key":"10.1016\/j.ijwd.2019.10.001_b0155","article-title":"The impact of dupilumab on patch testing and the prevalence of co-morbid ACD in recalcitrant atopic dermatitis","author":"Raffi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.10.001_b0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0536.1996.tb02148.x","article-title":"Facial dermatitis and eyelid dermatitis: a comparison of patch test results and final diagnoses","volume":"34","author":"Shah","year":"1996","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ijwd.2019.10.001_b0165","article-title":"Dupilumab-induced follicular conjunctivitis","author":"Shen","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ijwd.2019.10.001_b0170","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMc1700366","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"376","author":"Simpson","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2019.10.001_b0175","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ijwd.2019.10.001_b0180","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jdcr.2018.08.027","article-title":"The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy","volume":"4","author":"Suresh","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"10","key":"10.1016\/j.ijwd.2019.10.001_b0185","doi-asserted-by":"crossref","first-page":"1534Y1540","DOI":"10.1016\/j.intimp.2011.05.010","article-title":"Nickel allergy-promoting effects of microbial or inflammatory substances at the sensitization step in mice","volume":"11","author":"Takahashi","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.10.001_b0190","doi-asserted-by":"crossref","first-page":"28Y36","DOI":"10.1111\/all.12358","article-title":"The multiple factors affecting the association between atopic dermatitis and contact sensitization","volume":"69","author":"Thyssen","year":"2014","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.ijwd.2019.10.001_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2017.03.003","article-title":"Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis","volume":"77","author":"Thyssen","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.ijwd.2019.10.001_b0200","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamadermatol.2018.2690","article-title":"Risk factors for dupilumab-associated conjunctivitis in patients with atopic dermatitis","volume":"154","author":"Treister","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ijwd.2019.10.001_b0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-0536.1992.tb05242.x","article-title":"Eyelid dermatitis: An evaluation of 150 patients","volume":"27","author":"Valsecchi","year":"1992","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ijwd.2019.10.001_b0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2310\/6620.2009.08081","article-title":"Positive patch test reactions to lanolin: cross-sectional data from the North American Contact Dermatitis Group, 1994 to 2006","volume":"20","author":"Warshaw","year":"2009","journal-title":"Dermatitis"},{"issue":"4","key":"10.1016\/j.ijwd.2019.10.001_b0215","first-page":"287","article-title":"Terminology of contact dermatitis","volume":"50","author":"Wilkinson","year":"1970","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.10.001_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2018.01.034","article-title":"Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab\u2013clinical characteristics and treatment","volume":"6","author":"Wollenberg","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ijwd.2019.10.001_b0225","first-page":"1","article-title":"Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis","author":"Yamane","year":"2019","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.ijwd.2019.10.001_b0230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jdcr.2018.10.016","article-title":"Lifitegrast add-on treatment for dupilumab-induced ocular surface disease (DIOSD): A novel case report","volume":"5","author":"Zirwas","year":"2018","journal-title":"JAAD Case Rep"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519301030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519301030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:27:27Z","timestamp":1641565647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647519301030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2352647519301030"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.10.001","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD),,","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}